Evidence map›Paper›PMID 41760897›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2026

"Short-term prognosis of hypertensive emergencies and urgencies: second preliminary report of the ongoing Italian multicenter ERIDANO study".

Fabrizio Vallelonga, Marco Cesareo, Martina Sanapo, Barbara Maria Colombo, Alessandro Maloberti, Ilaria Fucile, Silvia Totaro, Carlo Aggiusti, Massimo Salvetti, Costantino Mancusi and 6 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Fabrizio Vallelonga *Division of Internal Medicine, Candiolo Cancer Institute FPO-IRCCS, Candiolo (Turin), Italy. fabrizio.vallelonga@ircc.it.
Marco Cesareo *Department of Medical Sciences, University of Turin, Turin, Italy.
Martina SanapoDepartment of Medical Sciences, University of Turin, Turin, Italy.
Barbara Maria ColomboClinic of Emergency Medicine, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
Alessandro MalobertiUniversity of Milan-Bicocca, Milan, Italy and Cardiology 4, ASST GOM Niguarda Hospital, Milan, Italy.
Ilaria FucileDepartment of Advanced Biomedical Science, Hypertension Research Center, "Federico II" University Hospital of Naples, Naples, Italy.
Silvia TotaroDepartment of Internal Medicine, A.O. Ordine Mauriziano, Turin, Italy.
Carlo AggiustiDepartment of Internal Medicine, ASST Spedali Civili of Brescia, University of Brescia, Brescia, Italy.
Massimo SalvettiDepartment of Internal Medicine, ASST Spedali Civili of Brescia, University of Brescia, Brescia, Italy.
Costantino MancusiDepartment of Advanced Biomedical Science, Hypertension Research Center, "Federico II" University Hospital of Naples, Naples, Italy.
Aldo PendeClinic of Emergency Medicine, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
Cristina GiannattasioUniversity of Milan-Bicocca, Milan, Italy and Cardiology 4, ASST GOM Niguarda Hospital, Milan, Italy.
Franco CipolliniDepartment of Medical Specialties, AUSL Toscana Centro, Internal Medicine Unit, San Marcello e San Jacopo I Hospital, Pistoia, Italy.
Maria Lorenza MuiesanDepartment of Internal Medicine, ASST Spedali Civili of Brescia, University of Brescia, Brescia, Italy.
Alberto MilanDivision of Internal Medicine, Candiolo Cancer Institute FPO-IRCCS, Candiolo (Turin), Italy.
Eridano Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertensive emergencies (HE) and urgencies (HU) are significant challenges for emergency physicians and hypertension specialists. The Eridano study is a prospective multicenter investigation assessing acute blood pressure (BP) disorders, subclinical hypertension-mediated organ damage (HMOD), and short- and long-term prognosis, including cardiovascular complications, new ED admissions, and BP control. Patients with symptomatic BP ≥ 180/110 mmHg admitted to the ED were enrolled and managed by ED personnel. Clinical evaluation and subclinical-HMOD assessment were performed at a Hypertension Centre within 72 h, followed by a 3-month follow-up. A total of 252 patients (21 HE, 231 HU) were included (mean age 61 ± 14 years, 52% males). Subclinical-HMOD was more common in HE (90% vs. 65%), including cardiac (76% vs. 43%), renal (40% vs. 11%), and cerebral (73% vs. 12%) damage. Vascular-HMOD was similar between the groups (54%), with increased pulse wave velocity (PWV) in 44% of patients. BP control (<140/90 mmHg) was achieved in 36% at 72 h. At 3 months, both groups showed lower systolic BP, and 29% of patients with uncontrolled BP at baseline achieved control. Female sex, lower ascending aorta diameter, and lower E/e' ratio were associated with BP control. The composite endpoint (cardiovascular events and new ED admissions) occurred in 12% of patients at 3 months (4% major events, 7% new HU). Multivariate analysis showed female sex and PWV were associated with adverse outcomes. Two-thirds of patients had subclinical HMOD, primarily affecting large arteries and the heart. Female sex and PWV were associated with worse outcomes.

Indexed as

HypertensionAgedAntihypertensive AgentsBlood PressureFemaleHumansHypertensive CrisisItalyMaleMiddle AgedPrognosisProspective StudiesAntihypertensive AgentsAcute hypertensionDigital hypertension.Morning hypertensionShort-term prognosisSubclinical hypertension-mediated organ damage

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.